Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain
In conclusion, the use of LAIs may play a role in the management of BPD.
Source: International Clinical Psychopharmacology - Category: Psychiatry Tags: Original Articles Source Type: research
More News: Abilify | Borderline Personality Disorder | Depression | Diazepam | Emergency Medicine | Invega | Psychiatry | Risperdal Consta | Spain Health | Study | Suicide | Valium